Who is sponsoring NCT03125512?

NCT03125512 is sponsored by Changi General Hospital.

What drugs are being tested in NCT03125512?

Interventions in NCT03125512: Night Shift positional device, continuous positive airway pressure.

What condition does NCT03125512 study?

NCT03125512 studies Sleep Apnea Syndromes.

Is NCT03125512 still recruiting?

NCT03125512 is currently completed. Last updated 7 May 2019.

Last reviewed 2019-05-07 · How we verify

NCT03125512

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Positional Therapy Versus CPAP for Positional OSA

Completed NA Last updated 7 May 2019

What this trial tests

NA trial testing Night Shift positional device in Sleep Apnea Syndromes in 41 participants. Completed in 30 December 2018.

Timeline

27 February 2017

Primary endpoint
10 December 2018

30 December 2018

Quick facts

Lead sponsor	Changi General Hospital
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	single
Primary purpose	treatment
Enrollment	41
Start date	27 February 2017
Primary completion	10 December 2018
Estimated completion	30 December 2018
Sites	1 location across Singapore

Drugs / interventions tested

Night Shift positional device
continuous positive airway pressure

Conditions studied

Sleep Apnea Syndromes — all drugs for Sleep Apnea Syndromes →

Sponsor

Changi General Hospital

Who can join

Adults 21 to 80, any sex, with Sleep Apnea Syndromes. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a crossover randomized controlled trial comparing a convenient positional therapy (PT) device to continuous positive airway pressure (CPAP) in the treatment of positional obstructive sleep apnea (OSA).

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Positional therapy for obstructive sleep apnoea.
Srijithesh PR, Aghoram R, Goel A, Dhanya J. · · 2019 · cited 40× · PMID 31041813 · DOI 10.1002/14651858.cd010990.pub2
Comparing treatment effects of a convenient vibratory positional device to CPAP in positional OSA: a crossover randomised controlled trial.
Mok Y, Tan A, Hsu PP, Seow A, et al · · 2020 · cited 19× · PMID 31896735 · DOI 10.1136/thoraxjnl-2019-213547

Verify or expand the search:

Other recruiting trials for Sleep Apnea Syndromes

Currently open trials in the same condition.

NCT06578390 — Efficacy Investigation of the Medical Device Apneal® on Smartphone for Sleep Apnea-Hypopnea Syndrome Diagnosis · NA · recruiting
NCT07086599 — Typological Study of Sleep Pathologies During Psoriatic Rheumatism and SAPHO Syndrome: Prospective Study Within the Pari · recruiting
NCT04399200 — Apnea, Stroke and Incident Cardiovascular Events · recruiting
NCT04234828 — Validation of Withings Sleep for the Detection of Sleep Apnea Syndrome · active not recruiting

Other Changi General Hospital trials

Trials by the same sponsor.

NCT07297745 — Trial of Aldosterone-hybrid SteRoid for Guiding curablE Treatment of Primary Aldosteronism (TARGET-PA) · NA · not yet recruiting
NCT07205133 — A Randomized Controlled Trial Comparing Whole Body Vibration Therapy With Usual Care and Usual Care to Improve Muscle He · NA · recruiting
NCT06970717 — Programmable Smart Watch for Remote Pre-habilitation/Rehabilitation Monitoring · NA · not yet recruiting
NCT06890169 — OneSTOP (One-Stop Telehealth Obesity Program) for Multidisciplinary Weight Management and Related Comorbidities · NA · recruiting
NCT06304415 — Elevated Lipoprotein(a) in Hospital Staff · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03125512 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Changi General Hospital
Last refreshed: 7 May 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03125512.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing